Show Notes
The interplay between genetics and medications is important but complex. Pharmacogenomic testing provides doctors with information about how individual patients may respond to certain medications (ie. fast and slow metabolisers). The RCPA recently released guidelines for doctors about requesting patient pharmacogenomic testing before prescribing some medications. These guidelines have identified 35 medications into three pharmacogenomics testing categories: recommend, consider, and no consensus. We discuss this testing with our guest today. This is the story of pharmacogenomics. RCPA guidelines: https://www.rcpa.edu.au/Library/Practising-Pathology/Pharmacogenomic-Indications-in-Australia Our special guest: Our special guest is Professor Luke Hessen who is the manager of the Genetics Department at Douglass Hanly Moir and co-Chair of the RCPA Pharmaogenetic Advisory Group. See omnystudio.com/listener for privacy information.
More from This Medical Life
Pleomorphic adenoma is the most common parotid tumour. ENT surgeon Dr Rowan Valentine covers assessment, red flags and surgery in Episode 112.
Professor Ken Sikaris explains the 2026 Australian prostate cancer early detection guidelines: new PSA thresholds by age, MRI's role and why free PSA is gone.
A patient with 200 sleep attacks a day helped define narcolepsy in 1880. Di Spillaine and Professor Robert Adams on symptoms, diagnosis and treatment today.
Dr Louise Stone on a decade of research into sexual harassment in medicine, why it persists, and what actually helps a colleague or trainee.
A 1901 case first identified Alzheimer's disease. Dr Daniel Clarke and Dr Gemma Daley on today's presentation, workup and new blood biomarker tests.